Mary Cushman: Unprovoked VTE as a Marker of Increased Cardiovascular Mortality Risk
Mary Cushman, University Distinguished Professor and Vice Chair at the University of Vermont, shared Debora Kamin Mukaz‘s post on LinkedIn, adding:
“Alert! People with unprovoked VTE have double the risk of death than those without VTE.
Their leading cause of death is circulatory disease.
When you are seeing patients with VTE think big picture.
Start a statin if indicated.
Get bold pressure less than 130.
Talk about smoking cessation.”
Debora Kamin Mukaz, Assistant Professor of Medicine at Larner College of Medicine at the University of Vermont, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Thrombosis and Haemostasis:
“We published a new paper on long-term mortality and causes of death after venous thromboembolism (VTE) in Journal of Thrombosis and Haemostasis (JTH).
People with any VTE were approximately 3 times more likely to die over 5 years than those without VTE.
The 5-year mortality risk were approximately 6-fold for cancer-provoked VTE and 2-fold for unprovoked and other-provoked VTE.
Those with cancer-provoked VTE were most likely to die of cancer, but circulatory diseases were the main causes of death after all other types of VTE.
This suggests that enhanced cardiovascular prevention in patients with VTE might delay mortality.”
Title: Long-term mortality and causes of death after venous thromboembolism: findings from the Atherosclerosis Risk in Communities Cohort Study
Authors: Debora Kamin Mukaz, Aixin Li, Weihua Guan, Rui Cao, Lingfeng Huo, Weihong Tang, Pamela L Lutsey, Neil A Zakai, Aaron R Folsom, Mary Cushman
Other posts featuring Mary Cushman on Hemostasis Today.
-
Apr 19, 2026, 13:31Danielle Plummer: Pulmonary Embolism in Pregnancy Requires Greater Awareness and Structured Evaluation
-
Apr 19, 2026, 13:27Mohammed Alo: Can Atherosclerosis Progress Even with a Zero Calcium Score
-
Apr 19, 2026, 13:24Anna Falanga: Clinical Impact and Advances in Patient Management of Cancer-Associated Thrombosis at the 13th ICTHIC
-
Apr 19, 2026, 13:17Santhosh Kumar Naidu: Garlic Activation and the Science of Allicin
-
Apr 19, 2026, 13:14Suzanne Fustolo-Gunnink: Exploring Complexity and Uncertainty in Transfusion Research
-
Apr 19, 2026, 13:04Tooba Rehman: Pulsed Field Ablation versus Thermal Ablation in Atrial Fibrillation
-
Apr 19, 2026, 12:55Toong Youttananukorn: WE CARE Study From India Showing the Needs of Patients and Caregivers
-
Apr 19, 2026, 12:51Immunofluorescence Blood Smear Analysis Validated for Diagnosing Inherited Platelet Disorders – JTH
-
Apr 19, 2026, 12:30Eve Glazier: A Physician’s Journey Living with Hemophilia A on The Latest Episode of UCLA Health Medically Speaking